In addition, a number of genes which have been identified as direct targets of CTNNB1/TCF transcriptional complexes correlate with improved CRC patient survival and have been shown to reduce CRC cell and tumor growth, such as CDX218 and EPHB319, 20. This evidence concerns the gene HNF4A and neoplasm.